|
G |
Bglap |
bone gamma-carboxyglutamate protein |
decreases expression |
ISO |
Calcium Carbonate results in decreased expression of BGLAP protein |
CTD |
PMID:2027271 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Capn1 |
calpain 1 |
increases activity |
ISO |
Calcium Carbonate analog results in increased activity of CAPN1 protein |
CTD |
PMID:24412303 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Calcium Carbonate analog results in increased activity of CASP3 protein |
CTD |
PMID:24412303 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Calcium Carbonate analog results in increased expression of DDIT3 |
CTD |
PMID:24412303 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Pth |
parathyroid hormone |
affects expression decreases expression |
ISO |
Calcium Carbonate affects the expression of PTH protein Calcium Carbonate results in decreased expression of PTH protein |
CTD |
PMID:1752077 PMID:2027271 PMID:3826069 PMID:7891547 PMID:8481062 PMID:16006300 More...
|
|
NCBI chr 1:167,508,121...167,511,530
Ensembl chr 1:167,508,598...167,511,530
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
decreases expression |
ISO |
Calcium Carbonate results in decreased expression of PTHLH protein |
CTD |
PMID:16006300 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
ISO |
Calcium Carbonate results in decreased expression of SPP1 protein |
CTD |
PMID:17977878 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions decreases activity |
EXP |
Lithium Carbonate promotes the reaction [sodium arsenite results in decreased activity of ALAD protein]; sodium arsenite promotes the reaction [Lithium Carbonate results in decreased activity of ALAD protein]; Zinc Sulfate inhibits the reaction [Lithium Carbonate results in decreased activity of ALAD protein] |
CTD |
PMID:19083387 PMID:28988373 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Casp1 |
caspase 1 |
increases expression |
ISO |
Lithium Carbonate results in increased expression of CASP1 protein |
CTD |
PMID:34984798 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases expression |
EXP ISO |
Lithium Carbonate results in increased activity of CASP3 protein Butylated Hydroxytoluene inhibits the reaction [Lithium Carbonate results in increased activity of CASP3 protein]; Cyclosporine inhibits the reaction [Lithium Carbonate results in increased activity of CASP3 protein] Lithium Carbonate results in increased expression of CASP3 protein |
CTD |
PMID:27588890 PMID:34984798 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases expression |
ISO |
Lithium Carbonate results in increased expression of CASP6 protein |
CTD |
PMID:34984798 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
increases expression |
ISO |
Lithium Carbonate results in increased expression of CASP7 protein |
CTD |
PMID:34984798 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
Lithium Carbonate results in increased expression of CASP9 protein |
CTD |
PMID:34984798 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
EXP ISO |
Lithium Carbonate results in decreased activity of CAT protein Lithium Carbonate promotes the reaction [sodium arsenite results in decreased activity of CAT protein]; sodium arsenite promotes the reaction [Lithium Carbonate results in decreased activity of CAT protein] |
CTD |
PMID:28988373 PMID:34984798 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity |
EXP |
Lithium Carbonate promotes the reaction [sodium arsenite results in decreased activity of GSR protein]; sodium arsenite promotes the reaction [Lithium Carbonate results in decreased activity of GSR protein] |
CTD |
PMID:28988373 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[Lithium Carbonate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression increases expression |
ISO |
Lithium Carbonate results in decreased expression of IL1B mRNA Lithium Carbonate results in increased expression of IL1B mRNA; Lithium Carbonate results in increased expression of IL1B protein |
CTD |
PMID:29594315 PMID:34984798 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Lithium Carbonate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Ins1 |
insulin 1 |
decreases expression multiple interactions |
EXP |
Lithium Carbonate results in decreased expression of INS1 protein Lithium Carbonate inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:10700396 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Mir21 |
microRNA 21 |
multiple interactions |
EXP |
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR21 mRNA; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR21 mRNA] |
CTD |
PMID:31928237 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir29b1 |
microRNA 29b-1 |
multiple interactions |
EXP |
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR29B1 mRNA; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of MIR29B1 mRNA] |
CTD |
PMID:31928237 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases phosphorylation |
ISO |
Lithium Carbonate results in increased phosphorylation of NFKBIA protein |
CTD |
PMID:34984798 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression |
ISO |
Lithium Carbonate results in increased expression of NLRP3 protein |
CTD |
PMID:34984798 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
EXP |
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of NOS3 protein; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of NOS3 protein] |
CTD |
PMID:31928237 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
decreases activity multiple interactions |
EXP |
Lithium Carbonate results in decreased activity of PFKFB2 protein Lithium Carbonate inhibits the reaction [Streptozocin results in decreased activity of PFKFB2 protein] |
CTD |
PMID:10700396 |
|
NCBI chr13:42,147,473...42,174,699
Ensembl chr13:42,147,478...42,174,699
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
increases expression |
ISO |
Lithium Carbonate results in increased expression of PLA2G4A mRNA; Lithium Carbonate results in increased expression of PLA2G4A protein |
CTD |
PMID:17594078 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Pth |
parathyroid hormone |
increases expression |
ISO |
Lithium Carbonate results in increased expression of PTH protein |
CTD |
PMID:3083797 PMID:18234408 |
|
NCBI chr 1:167,508,121...167,511,530
Ensembl chr 1:167,508,598...167,511,530
|
|
G |
Pycard |
PYD and CARD domain containing |
increases expression |
ISO |
Lithium Carbonate results in increased expression of PYCARD protein |
CTD |
PMID:34984798 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases phosphorylation |
ISO |
Lithium Carbonate results in increased phosphorylation of RELA protein |
CTD |
PMID:34984798 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
Lithium Carbonate results in increased expression of TNF mRNA; Lithium Carbonate results in increased expression of TNF protein |
CTD |
PMID:34984798 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnni3 |
troponin I3, cardiac type |
multiple interactions |
EXP |
[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of TNNI3 protein; Acetylcysteine inhibits the reaction [[Lithium Carbonate results in increased abundance of Lithium] which results in increased expression of TNNI3 protein] |
CTD |
PMID:31928237 |
|
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
|
|